Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're still hungry three days into Mounjaro, that's completely normal and doesn't mean the medicine isn't working. The 2.5mg starting dose is designed to let your body adjust gently, not to suppress appetite straight away — most people notice the appetite effect building gradually over the first few weeks, not within the first few days. Mounjaro is a prescription-only medicine; a prescriber decides whether it's clinically appropriate for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) works by activating two gut-hormone receptors (GIP and GLP-1) that are involved in appetite regulation, blood-sugar control and gastric emptying. But none of that happens at full intensity on day three of a 2.5mg dose. The starting dose exists primarily to reduce the chance of nausea and other gastrointestinal side effects as your body adapts. Think of it as your system learning a new setting rather than flipping a switch.
At 2.5mg, the receptor activation is real but modest. Gastric emptying slows a little, meaning food stays in your stomach slightly longer than before, but many people don't feel that difference yet. The brain signals that reduce appetite and increase fullness take time to calibrate. This is why clinical trials ran for 72 weeks, not 72 hours. The appetite suppression that participants in the SURMOUNT-1 trial reported (average weight reduction of around 20–21% at the 15mg maintenance dose) built over many months of titration, not a few days at the lowest dose.
So if you finished your Tuesday injection and woke up Thursday still hungry, that is exactly where you should be. The full picture of how Mounjaro works may help set expectations before your first dose increase.
Most people describe a gradual quietening of appetite rather than a sudden silence. The first sign is often not dramatic: lunch feels slightly more satisfying than usual, or you reach the end of a meal without thinking about what comes next. For many, this becomes more obvious in weeks two and three of the first pen, and again after the step up to 5mg.
Day three specifically tends to fall before the medicine has reached steady-state tissue levels, the body is still processing the initial dose. If you were previously eating in response to strong hunger cues, those cues won't have changed yet. Being hungry at this point is your biology doing exactly what it has always done, not evidence that tirzepatide is failing you.
There's a useful parallel with how exercise works: the cardiovascular benefits of a new running routine don't appear after the first three runs. The physiological change needs time. Patience here is not passive, it's the correct clinical posture. Our guide to persistent hunger on Mounjaro explores what to expect as titration progresses.
This is where you have real agency in those early days. Because the medicine's appetite effect is still mild, leaning on high-satiety foods reduces the gap between where Mounjaro currently is and where your hunger would like to be. Protein is the most effective single lever: it slows stomach emptying, supports muscle mass (important when in a calorie deficit) and promotes fullness hormones independently of tirzepatide. Aim to make it the centrepiece of every meal rather than a side note.
Fibre plays a similar role, vegetables, pulses and wholegrains add bulk without large calorie loads, and slow digestion in a way that compounds Mounjaro's own gastric-emptying effect. Meals heavy in refined carbohydrates or ultra-processed foods tend to digest quickly, which can leave you hungry again within a couple of hours regardless of the medicine.
Timing matters too. Some people find that eating earlier in the day (breakfast and a mid-morning meal rather than relying on a large evening meal) fits better with how Mounjaro affects their appetite once it does build. For breakfast ideas that tend to work well, the Mounjaro breakfast guide is worth reading before your next morning. Our broader food guide for Mounjaro covers the full picture of eating well alongside treatment.
One practical detail: many people take their Mounjaro injection on a specific day each week and then find that the day or two before the next injection, hunger creeps back a little. That's a recognised pattern, and worth noting in a food diary so you can plan accordingly rather than being caught off guard. Knowing the day your pen goes in, and roughly when you'll be at peak effect versus trough, lets you plan meals ahead of time, the same way knowing your 12pm injection deadline on a weekday helps you plan the rest of the afternoon.
If you're wondering about the timing of food around the injection itself, the question of taking Mounjaro after food is covered separately, including what the patient information leaflet says about injection timing.
Hunger at day three is not a reason to contact your prescriber. It is, however, worth keeping track of how it changes over the first four weeks, a simple note on your phone works fine. If by the end of the first pen you've noticed no change at all in appetite, or if hunger is severe enough to be distressing, that's genuinely worth mentioning at your next clinical review. A prescriber can assess whether the titration schedule, dose timing or food approach needs adjusting.
On the other hand, some people experience the opposite: appetite falls quite sharply after starting, sometimes to the point of eating too little. If that's a concern, our guide to not feeling hungry on Mounjaro explains what to do. Both ends of the spectrum are worth monitoring, and both are conversations worth having with your clinical team rather than managing alone.
The NHS guidance on tirzepatide notes that individual responses vary, and that food and lifestyle changes work alongside the medicine rather than being replaced by it. The NHS tirzepatide page and the NHS England weight-management injections guidance both reinforce that dietary support is part of treatment, not optional. If you're still working out whether Mounjaro is the right route for you, the weight-loss treatments page sets out what a clinical consultation involves and how to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.